O-RADSâ„¢ Ultrasound
O-RADS US offers imaging and clinical management recommendations with risk assessment categories to optimize patient outcomes.
Current Release
O-RADS US v2022 was updated in November 2022 and is available on the web and for download.
Ultrasound is the primary imaging modality of the female pelvis which allows adequate evaluation of most adnexal lesions using transvaginal and transabdominal technique. The O-RADS US lexicon uses terms supported in the literature and by the International Ovarian Tumor Analysis (IOTA) group to describe ovarian/adnexal lesions and assign a risk of malignancy. Imaging and clinical management recommendations accompany the risk assessment categories to optimize patient outcomes.
Further reading:
Putting O-RADS US to Work
Technical Guidance
Specifications for Ultrasound Exams
ºÚÁÏÍø Guidance App
O-RADS US Calculator
Reporting
How to Report/Sample Reports
Template
Reporting Template Sample
FAQ
O-RADS US Frequently Asked Questions
Incorporating O-RADSâ„¢ US v2022 in Daily Clinical PracticeEducation Activity
Request Permission for O-RADS
Additional Educational Information
O-RADS US Literature
License Information
Reporting and Data Systems (RADS) by the ºÚÁÏÍø are licensed under a . Permissions beyond the scope of this license may be available by using our . Contact us: rads@acr.org